Document Details
Form
Filing Date
Feb 28, 2024
Document Date
Feb 27, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
Filer
Duker Jay S.
